In 4T1 tumour-bearing mice, IDO inhibition reduced the immune-suppressive tumour microenvironment by attenuating Treg and M2-TAM infiltration, resulting in substantial primary tumour regression and reduced lung metastasis. Here, IDO1 is linked to neoplasm.